A Texas-based biotech becomes the latest to enter the SPAC scene
A biotech located in Texas’ capital will be looking to enter a SPAC deal.
On Monday, the Dallas-based SPAC Financial Strategies Acquisition Corp. announced it …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.